Aim of the study: To evaluate GIP and GLP-1 secretion in postmenopausal women on the HRT in relation togestagen used. Material and method: 105 postmenopausal women (mean age 59.0 ±3.4 years) were included in the study.Group I (n = 32) consisted of women ...
Iwona Rogatko+3 more
doaj
Reduction of estrogen and progestogen doses is one of the main trends in oral menopausal hormonetherapy (MHT). Studies on ultra low oral MHT, composed of 0,5 mg estradiol plus reduced doses of variousprogestoagens (e.g.
Tomasz Pertyński, Grzegorz Stachowiak
doaj
Amna Abdalla Mohammed Khalid+8 more
semanticscholar +1 more source
Pregnancy Rate Is High When the Length of the Luteal Phase During the In Vitro Fertilization Hormone Replacement Cycle Is 144 Hours or More Before Embryo Transfer. [PDF]
Nishio E+8 more
europepmc +1 more source
Cytokines, Hormones and Cellular Regulatory Mechanisms Favoring Successful Reproduction [PDF]
Piccinni, Mp+3 more
core
Unmasking the risk: clinical trials versus real-world evidence on dydrogesterone and birth defects. [PDF]
Parazzini F, Cantarutti A, Esposito G.
europepmc +1 more source
Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial. [PDF]
Rinaldi L, Crescenzi F, Selman H.
europepmc +1 more source
Vaginal micronized progesterone on preventing luteinizing hormone untimely surge in ART cycles: A prospective proof-of-concept study. [PDF]
Souza MDCB+6 more
europepmc +1 more source
Sanji Peiyuan decoction combined with dydrogesterone in the treatment of massive subchorionic hematoma: A case report. [PDF]
Yang Y+6 more
europepmc +1 more source
Luteal Phase Support in ART: An Update [PDF]
Al-Boghdady, Laila A.+1 more
core +2 more sources